Recent clinical interest has focused on whether GLP-1 receptor agonists like semaglutide might address the underlying appetite dysregulation in PWS patients
Malaguarnera, M., Vacante, M., Giordano, M., Motta, M., Bertino, G., Pennisi, M., Neri, S., Malaguarnera, M., Li, Volti G., and Galvano, F
The enhancement of active endogenous GLP-1 leads to increased insulin but reduced glucagon secretion, in addition to delaying gastric emptying and supressing appetite ( Pathophysiology of T2D is characterized by predominant insulin resistance than impaired insulin secretion in Caucasians whereas impaired insulin secretion rather than insulin resistance predominates in Asians ( It is apparent that the therapeutic effects of DPP-IV inhibitors in Asians are more pronounced compared with Caucasians
19 g protein
Ashwagandha is another relaxation-promoting ingredient
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice